Literature DB >> 10734312

Constitutive activation of the Ras/MAP kinase pathway and enhanced TCR signaling by targeting the Shc adaptor to membrane rafts.

S Plyte1, M B Majolini, S Pacini, F Scarpini, C Bianchini, L Lanfrancone, P Pelicci, C T Baldari.   

Abstract

The Shc adaptor is responsible for coupling receptor tyrosine kinases and tyrosine kinase-associated receptors to the Ras/MAP kinase pathway. Shc is believed to be regulated by a change in subcellular localization from the cytosol to the plasma membrane, where it recruits Grb-2/Sos complexes and hence permits juxtaposition of the guanine nucleotide exchange factor Sos to Ras, resulting in GDP/GTP exchange and Ras activation. Shc has been recently shown to inducibly colocalize in detergent-resistant membrane rafts together with the activated TCR and associated signaling molecules. To understand whether Shc localization in membrane rafts is sufficient to regulate Shc function, we constructed a Shc chimera containing the Ras membrane localization motif at the C-terminus. We show that membrane targeted Shc was constitutively localized in the plasma membrane of T-cells, and was mostly compartmentalized in lipid rafts. Membrane targeted Shc was phosphorylated on tyrosine residues and bound Grb-2/Sos in the absence of TCR engagement. Furthermore, expression of membrane targeted Shc resulted in constitutive downstream signaling, including Erk2 activation and enhancement of TCR dependent activation of the TCR responsive transcription factor NF-AT. Hence localization of Shc in membrane rafts is sufficient for Shc to acquire a signaling competent state. Interestingly, a membrane targeted Shc mutant lacking both Grb-2 binding sites was not only incapable of signaling in the absence of TCR triggering, but transdominantly inhibited endogenous Shc, supporting a non redundant role for Shc in the activation of the Ras/MAP kinase pathway in T-cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10734312     DOI: 10.1038/sj.onc.1203451

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  12 in total

1.  EMBO WORKSHOP REPORT: lymphocyte antigen receptor and coreceptor signaling Siena, Italy, November 6-10, 1999.

Authors:  C T Baldari; J L Telford; O Acuto
Journal:  EMBO J       Date:  2000-09-15       Impact factor: 11.598

2.  Genetic evidence for Shc requirement in TCR-induced c-Rel nuclear translocation and IL-2 expression.

Authors:  Makio Iwashima; Masako Takamatsu; Hiroko Yamagishi; Yasue Hatanaka; Yi-Ying Huang; Courtnie McGinty; Sho Yamasaki; Toru Koike
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-26       Impact factor: 11.205

Review 3.  A Link Between Alzheimer's and Type II Diabetes Mellitus? Ca+2 -Mediated Signal Control and Protein Localization.

Authors:  Yuko Tsutsui; Franklin A Hays
Journal:  Bioessays       Date:  2018-04-25       Impact factor: 4.345

4.  Docking protein FRS2 links the protein tyrosine kinase RET and its oncogenic forms with the mitogen-activated protein kinase signaling cascade.

Authors:  R M Melillo; M Santoro; S H Ong; M Billaud; A Fusco; Y R Hadari; J Schlessinger; I Lax
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

5.  ShcA mediates the dominant pathway to extracellular signal-regulated kinase activation during early thymic development.

Authors:  Paul Trampont; Li Zhang; Kodi S Ravichandran
Journal:  Mol Cell Biol       Date:  2006-09-18       Impact factor: 4.272

Review 6.  Lipid raft redox signaling: molecular mechanisms in health and disease.

Authors:  Si Jin; Fan Zhou; Foad Katirai; Pin-Lan Li
Journal:  Antioxid Redox Signal       Date:  2011-05-11       Impact factor: 8.401

7.  Molecular dynamics simulations reveal that Tyr-317 phosphorylation reduces Shc binding affinity for phosphotyrosyl residues of epidermal growth factor receptor.

Authors:  Atsushi Suenaga; Mariko Hatakeyama; Anatoly B Kiyatkin; Ravi Radhakrishnan; Makoto Taiji; Boris N Kholodenko
Journal:  Biophys J       Date:  2009-03-18       Impact factor: 4.033

8.  p66shc negatively regulates insulin-like growth factor I signal transduction via inhibition of p52shc binding to Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 leading to impaired growth factor receptor-bound protein-2 membrane recruitment.

Authors:  Gang Xi; Xinchun Shen; David R Clemmons
Journal:  Mol Endocrinol       Date:  2008-07-07

9.  Extensive temporally regulated reorganization of the lipid raft proteome following T-cell antigen receptor triggering.

Authors:  Luca Bini; Sonia Pacini; Sabrina Liberatori; Silvia Valensin; Michela Pellegrini; Roberto Raggiaschi; Vitaliano Pallini; Cosima T Baldari
Journal:  Biochem J       Date:  2003-01-15       Impact factor: 3.857

10.  p66SHC promotes apoptosis and antagonizes mitogenic signaling in T cells.

Authors:  Sonia Pacini; Michela Pellegrini; Enrica Migliaccio; Laura Patrussi; Cristina Ulivieri; Andrea Ventura; Fabio Carraro; Antonella Naldini; Luisa Lanfrancone; Piergiuseppe Pelicci; Cosima T Baldari
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.